SCHEMBL25071206

SCHEMBL25071206

CCC(C)N1CCNCC12CC2

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.40
▸ SOS2 Q07890 1/20 0.40
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17789639 0.80 SOS1 (0.45) SOS1SOS2
SCHEMBL27881669 0.79 — —
SCHEMBL28736185 0.76 — —
SCHEMBL25785125 0.76 CYP1A2 (0.30) —
SCHEMBL27443832 0.73 SOS1 (0.52) SOS1SOS2
SCHEMBL21216979 0.73 CYP1A2 (0.32) SOS1SOS2
SCHEMBL19122108 0.72 DPP4 (0.30) —
SCHEMBL25125594 0.71 — —
SCHEMBL12523367 0.68 SOS1 (0.45) SOS1SOS2TSHR
SCHEMBL21323268 0.68 DPP4 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230053746-A1 IL-17 LIGANDS AND USES THEREOF DICE MOLECULES SV, INC. 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230053746-A1 IL-17 LIGANDS AND USES THEREOF IL17A, IL2, IL15 SOS1 2707/4885SOS2 2701/4885TSHR 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback